We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -15.00 | -0.91% | 1,636.00 | 1,638.00 | 1,639.00 | 1,661.50 | 1,635.50 | 1,656.50 | 4,329,161 | 16:35:12 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.69 | 67.46B |
From Apr 2019 to Apr 2024
TIDMGSK
RNS Number : 2974U
GlaxoSmithKline PLC
16 January 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
Hot Features
Premium
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Sir Andrew Witty
=== ======================== ================================================
b) Position/status Chief Executive Officer
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP15.66 406.772 (personal contribution)
--------- --------------------------------
GBP15.66 406.759 (personal contribution)
--------- --------------------------------
GBP15.66 203.865 (personal contribution)
--------- --------------------------------
GBP15.66 203.865 (personal contribution)
--------- --------------------------------
GBP15.66 510.713 (personal contribution)
--------- --------------------------------
GBP15.66 406.772 (matching shares)
--------- --------------------------------
GBP15.66 406.759 (matching shares)
--------- --------------------------------
GBP15.66 203.865 (matching shares)
--------- --------------------------------
GBP15.66 203.865 (matching shares)
--------- --------------------------------
GBP15.66 510.713 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
3,463.948
GBP15.66
=== ======================== ================================================
e) Date of the transaction 2017-01-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Ms E Walmsley
=== ======================== ================================================
b) Position/status CEO Designate
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP15.66 89.065 (personal contribution)
--------- --------------------------------
GBP15.66 89.065 (personal contribution)
--------- --------------------------------
GBP15.66 71.015 (personal contribution)
--------- --------------------------------
GBP15.66 71.015 (personal contribution)
--------- --------------------------------
GBP15.66 175.863 (personal contribution)
--------- --------------------------------
GBP15.66 175.850 (personal contribution)
--------- --------------------------------
GBP15.66 89.065 (matching shares)
--------- --------------------------------
GBP15.66 89.065 (matching shares)
--------- --------------------------------
GBP15.66 71.015 (matching shares)
--------- --------------------------------
GBP15.66 71.015 (matching shares)
--------- --------------------------------
GBP15.66 175.863 (matching shares)
--------- --------------------------------
GBP15.66 175.850 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
1,343.746
GBP15.66
=== ======================== ================================================
e) Date of the transaction 2017-01-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr R G Connor
=== ======================== ================================================
b) Position/status President, Global Manufacturing & Supply
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP15.66 79.620 (personal contribution)
--------- --------------------------------
GBP15.66 79.607 (personal contribution)
--------- --------------------------------
GBP15.66 52.007 (personal contribution)
--------- --------------------------------
GBP15.66 52.007 (personal contribution)
--------- --------------------------------
GBP15.66 119.484 (personal contribution)
--------- --------------------------------
GBP15.66 79.620 (matching shares)
--------- --------------------------------
GBP15.66 79.607 (matching shares)
--------- --------------------------------
GBP15.66 52.007 (matching shares)
--------- --------------------------------
GBP15.66 52.007 (matching shares)
--------- --------------------------------
GBP15.66 119.484 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
765.45
GBP15.66
=== ======================== ================================================
e) Date of the transaction 2017-01-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr S Dingemans
=== ======================== ================================================
b) Position/status Chief Financial Officer
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP15.66 192.213 (personal contribution)
--------- --------------------------------
GBP15.66 76.874 (personal contribution)
--------- --------------------------------
GBP15.66 99.193 (personal contribution)
--------- --------------------------------
GBP15.66 99.180 (personal contribution)
--------- --------------------------------
GBP15.66 232.242 (personal contribution)
--------- --------------------------------
GBP15.66 232.229 (personal contribution)
--------- --------------------------------
GBP15.66 192.213 (matching shares)
--------- --------------------------------
GBP15.66 76.874 (matching shares)
--------- --------------------------------
GBP15.66 99.193 (matching shares)
--------- --------------------------------
GBP15.66 99.180 (matching shares)
--------- --------------------------------
GBP15.66 232.242 (matching shares)
--------- --------------------------------
GBP15.66 232.229 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
1,863.862
GBP15.66
=== ======================== ================================================
e) Date of the transaction 2017-01-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr N Hirons
=== ======================== ================================================
b) Position/status SVP, Global Ethics & Compliance
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- -------------------------------
GBP15.66 36.414 (personal contribution)
--------- -------------------------------
GBP15.66 36.414 (personal contribution)
--------- -------------------------------
GBP15.66 85.869 (personal contribution)
--------- -------------------------------
GBP15.66 85.869 (personal contribution)
--------- -------------------------------
GBP15.66 36.414 (matching shares)
--------- -------------------------------
GBP15.66 36.414 (matching shares)
--------- -------------------------------
GBP15.66 85.869 (matching shares)
--------- -------------------------------
GBP15.66 85.869 (matching shares)
--------- -------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
489.132
GBP15.66
=== ======================== ================================================
e) Date of the transaction 2017-01-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr S A Hussain
=== ======================== ================================================
b) Position/status President, Global Pharmaceuticals
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP15.66 116.783 (personal contribution)
--------- --------------------------------
GBP15.66 171.654 (personal contribution)
--------- --------------------------------
GBP15.66 202.916 (personal contribution)
--------- --------------------------------
GBP15.66 202.916 (personal contribution)
--------- --------------------------------
GBP15.66 116.783 (matching shares)
--------- --------------------------------
GBP15.66 171.654 (matching shares)
--------- --------------------------------
GBP15.66 202.916 (matching shares)
--------- --------------------------------
GBP15.66 202.916 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
1,388.538
GBP15.66
=== ======================== ================================================
e) Date of the transaction 2017-01-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr D S Redfern
=== ======================== ================================================
b) Position/status Chief Strategy Officer
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP15.66 72.618 (personal contribution)
--------- --------------------------------
GBP15.66 72.605 (personal contribution)
--------- --------------------------------
GBP15.66 58.351 (personal contribution)
--------- --------------------------------
GBP15.66 58.351 (personal contribution)
--------- --------------------------------
GBP15.66 109.284 (personal contribution)
--------- --------------------------------
GBP15.66 109.284 (personal contribution)
--------- --------------------------------
GBP15.66 72.618 (matching shares)
--------- --------------------------------
GBP15.66 72.605 (matching shares)
--------- --------------------------------
GBP15.66 58.351 (matching shares)
--------- --------------------------------
GBP15.66 58.351 (matching shares)
--------- --------------------------------
GBP15.66 109.284 (matching shares)
--------- --------------------------------
GBP15.66 109.284 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
960.986
GBP15.66
=== ======================== ================================================
e) Date of the transaction 2017-01-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Dr M M Slaoui
=== ======================== ===============================================
b) Position/status Chairman, Global Vaccines
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 12 January 2017 on ADSs
held in the Company's 2009 Deferred Annual
Bonus Plan.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
$39.01 125.340 (personal contribution)
--------- --------------------------------
$39.01 125.327 (personal contribution)
--------- --------------------------------
$39.01 78.047 (personal contribution)
--------- --------------------------------
$39.01 78.047 (personal contribution)
--------- --------------------------------
$39.01 128.475 (personal contribution)
--------- --------------------------------
$39.01 128.475 (personal contribution)
--------- --------------------------------
$39.01 125.340 (matching shares)
--------- --------------------------------
$39.01 125.327 (matching shares)
--------- --------------------------------
$39.01 78.047 (matching shares)
--------- --------------------------------
$39.01 78.047 (matching shares)
--------- --------------------------------
$39.01 128.475 (matching shares)
--------- --------------------------------
$39.01 128.475 (matching shares)
--------- --------------------------------
=== ======================== ===============================================
d) Aggregated information
Aggregated volume
Price
1,327.422
$39.01
=== ======================== ===============================================
e) Date of the transaction 2017-01-12
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Ms C Thomas
=== ======================== ================================================
b) Position/status SVP, Human Resources
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP15.66 90.103 (personal contribution)
--------- --------------------------------
GBP15.66 78.542 (personal contribution)
--------- --------------------------------
GBP15.66 78.530 (personal contribution)
--------- --------------------------------
GBP15.66 159.879 (personal contribution)
--------- --------------------------------
GBP15.66 159.879 (personal contribution)
--------- --------------------------------
GBP15.66 90.103 (matching shares)
--------- --------------------------------
GBP15.66 78.542 (matching shares)
--------- --------------------------------
GBP15.66 78.530 (matching shares)
--------- --------------------------------
GBP15.66 159.879 (matching shares)
--------- --------------------------------
GBP15.66 159.879 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
1,133.866
GBP15.66
=== ======================== ================================================
e) Date of the transaction 2017-01-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr P C Thomson
=== ======================== ================================================
b) Position/status SVP, Communications & Government Affairs
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- -------------------------------
GBP15.66 54.266 (personal contribution)
--------- -------------------------------
GBP15.66 53.347 (personal contribution)
--------- -------------------------------
GBP15.66 97.819 (personal contribution)
--------- -------------------------------
GBP15.66 54.266 (matching shares)
--------- -------------------------------
GBP15.66 53.347 (matching shares)
--------- -------------------------------
GBP15.66 97.819 (matching shares)
--------- -------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
410.864
GBP15.66
=== ======================== ================================================
e) Date of the transaction 2017-01-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Mr D E Troy
=== ======================== ===============================================
b) Position/status SVP & General Counsel
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 12 January 2017 on ADSs
held in the Company's 2009 Deferred Annual
Bonus Plan.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- -------------------------------
$39.01 50.726 (personal contribution)
--------- -------------------------------
$39.01 50.726 (personal contribution)
--------- -------------------------------
$39.01 40.386 (personal contribution)
--------- -------------------------------
$39.01 40.386 (personal contribution)
--------- -------------------------------
$39.01 90.932 (personal contribution)
--------- -------------------------------
$39.01 90.932 (personal contribution)
--------- -------------------------------
$39.01 50.726 (matching shares)
--------- -------------------------------
$39.01 50.726 (matching shares)
--------- -------------------------------
$39.01 40.386 (matching shares)
--------- -------------------------------
$39.01 40.386 (matching shares)
--------- -------------------------------
$39.01 90.932 (matching shares)
--------- -------------------------------
$39.01 90.932 (matching shares)
--------- -------------------------------
=== ======================== ===============================================
d) Aggregated information
Aggregated volume
Price
728.176
$39.01
=== ======================== ===============================================
e) Date of the transaction 2017-01-12
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Dr P J T Vallance
=== ======================== ================================================
b) Position/status President, Pharmaceuticals R&D
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP15.66 161.014 (personal contribution)
--------- --------------------------------
GBP15.66 161.001 (personal contribution)
--------- --------------------------------
GBP15.66 115.614 (personal contribution)
--------- --------------------------------
GBP15.66 115.614 (personal contribution)
--------- --------------------------------
GBP15.66 188.068 (personal contribution)
--------- --------------------------------
GBP15.66 188.068 (personal contribution)
--------- --------------------------------
GBP15.66 161.014 (matching shares)
--------- --------------------------------
GBP15.66 161.001 (matching shares)
--------- --------------------------------
GBP15.66 115.614 (matching shares)
--------- --------------------------------
GBP15.66 115.614 (matching shares)
--------- --------------------------------
GBP15.66 188.068 (matching shares)
--------- --------------------------------
GBP15.66 188.068 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
1,858.758
GBP15.66
=== ======================== ================================================
e) Date of the transaction 2017-01-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHVQLFFDFFLBBB
(END) Dow Jones Newswires
January 16, 2017 13:25 ET (18:25 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
